Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

SZSE:002399.SZ

11.65 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012201120102009200820072006
Operating Activities:
Net Income -783.258714.687233.3831,021.6321,043.554592.184118.189386.118568.078335.331313.42616.551618.9381,208.795809.057161.39368.16147.884
Depreciation & Amortization 384.667307.659302.745303.992255.595217.025155.154161.78497.89838.60924.8316.58112.3511.0036.715.9115.1420
Deferred Income Tax -237.627-43.3-170.556172.67599.356-11.834-167.095-20.83816.321000000000
Stock Based Compensation 000.1910.3190.3180000009.52000000
Change In Working Capital -563.055-2,311.251-1,125.12-765.43-1,029.854-584.947-963.145-217.235239.711497.04655.523-162.445772.092-854.038-467.645-136.4-71.5310
Accounts Receivables 270.548-176.104141.771-346.748-479.161-334.924-1,041.07-236.674-188.23657.094112.547-147.224000000
Inventory -619.669-2,151.556-1,520.236-763.876-744.392-254.255-301.241-31.097466.527338.788-128.133-93.307735.227-612.674-319.863-171.7858.3690
Accounts Payables -213.93459.708423.9172.5294.344232.6631.85471.374-54.902000000000
Other Working Capital -451.562-43.3-170.556172.67599.356-330.692-661.904-186.138-226.816158.259183.656-69.13736.865-241.364-147.78135.385-79.90
Other Non Cash Items 3,003.05532.292752.728-695.903-596.57443.608282.68615.405-11.9841.81727.1963.2031.833-10.8967.6849.22312.076-47.884
Operating Cash Flow 471.388-756.613-6.62937.284-227.602667.869-407.117346.072893.707912.804420.969473.891,405.212354.864355.80640.12813.8470
Investing Activities:
Investments In Property Plant And Equipment -444.878-222.421-193.861-212.49-362.076-535.009-576.131-359.536-168.849-167.623-293.975-237.547-134.163-35.933-54.914-10.812-11.952-10.706
Acquisitions Net -4.863-01.7180.220.02327.1721.37360.427-1,207.093-1,384.433294.06300000010.706
Purchases Of Investments -758.247-4,482.674-2,370.162-1,763.5-1,941.518-899.329-2,204.544-1,891.239-2,188.888-1,592.502-194.160-7.20000-0.32
Sales Maturities Of Investments 2,349.3114,210.723,305.1251,027.031,914.085865.3151,628.0421,976.8681,908.628331.40181.406000000.520.15
Other Investing Activites -0.127744.215-22.892-1,225.024391.189-2.452-55.336-359.5360.280.783-293.9750.0670.1520.001-54.9140.083-11.952-10.706
Investing Cash Flow 1,141.197249.84719.928-2,173.7641.703-544.303-1,206.598-273.017-1,655.922-2,812.373-406.641-237.479-141.212-35.933-54.914-10.729-11.432-10.876
Financing Activities:
Debt Repayment 000000000000000000
Common Stock Issued 000000000000000000
Common Stock Repurchased 0000000-472.9960000000000
Dividends Paid -146.73-51.355-220.094-224.496-342.512-255.141-444.585-541.436-292.268-262.565-480.187-480.12-800.2-5.489-67.58-19.522-59.388-10.799
Other Financing Activities -325.3786,616.8283,641.9628,151.3684,778.0462,764.2062,998.0831,676.6921,136.1071,656.02577.71558.34451.65,962.881274.667300.34336.948286.648
Financing Cash Flow -1,202.972329.564-501.0812,506.462-234.335-1,616.105564.47274.224809.892-26.573-552.087-421.776-748.65,494.336-16.64199.73-122.43958.032
Other Information:
Effect Of Forex Changes On Cash 36.32517.283-62.83-116.27310.67119.428-6.28113.06911.1981.883-0.4460.008-0.20600-000
Net Change In Cash -287.137-159.926149.388253.708-449.563-1,473.111-1,055.526360.34958.875-1,924.259-538.205-185.357515.1955,813.267284.251129.129-120.024118.814
Cash At End Of Period 1,851.6421,319.7071,479.6331,330.2451,076.5372,117.9093,489.7144,545.244,184.8924,126.0166,050.2766,588.4816,773.8386,258.643445.376161.12631.997152.02